Correlation Between Ocuphire Pharma and Orchestra BioMed
Can any of the company-specific risk be diversified away by investing in both Ocuphire Pharma and Orchestra BioMed at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ocuphire Pharma and Orchestra BioMed into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Ocuphire Pharma and Orchestra BioMed Holdings, you can compare the effects of market volatilities on Ocuphire Pharma and Orchestra BioMed and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ocuphire Pharma with a short position of Orchestra BioMed. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ocuphire Pharma and Orchestra BioMed.
Diversification Opportunities for Ocuphire Pharma and Orchestra BioMed
0.59 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Ocuphire and Orchestra is 0.59. Overlapping area represents the amount of risk that can be diversified away by holding Ocuphire Pharma and Orchestra BioMed Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Orchestra BioMed Holdings and Ocuphire Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ocuphire Pharma are associated (or correlated) with Orchestra BioMed. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Orchestra BioMed Holdings has no effect on the direction of Ocuphire Pharma i.e., Ocuphire Pharma and Orchestra BioMed go up and down completely randomly.
Pair Corralation between Ocuphire Pharma and Orchestra BioMed
Given the investment horizon of 90 days Ocuphire Pharma is expected to under-perform the Orchestra BioMed. But the stock apears to be less risky and, when comparing its historical volatility, Ocuphire Pharma is 1.26 times less risky than Orchestra BioMed. The stock trades about -0.07 of its potential returns per unit of risk. The Orchestra BioMed Holdings is currently generating about 0.0 of returns per unit of risk over similar time horizon. If you would invest 667.00 in Orchestra BioMed Holdings on August 28, 2024 and sell it today you would lose (110.00) from holding Orchestra BioMed Holdings or give up 16.49% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 82.54% |
| Values | Daily Returns |
Ocuphire Pharma vs. Orchestra BioMed Holdings
Performance |
| Timeline |
| Ocuphire Pharma |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| Orchestra BioMed Holdings |
Ocuphire Pharma and Orchestra BioMed Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Ocuphire Pharma and Orchestra BioMed
The main advantage of trading using opposite Ocuphire Pharma and Orchestra BioMed positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ocuphire Pharma position performs unexpectedly, Orchestra BioMed can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Orchestra BioMed will offset losses from the drop in Orchestra BioMed's long position.| Ocuphire Pharma vs. Reviva Pharmaceuticals Holdings | Ocuphire Pharma vs. Protalix Biotherapeutics | Ocuphire Pharma vs. Eyepoint Pharmaceuticals | Ocuphire Pharma vs. Sellas Life Sciences |
| Orchestra BioMed vs. BCE Inc | Orchestra BioMed vs. CECO Environmental Corp | Orchestra BioMed vs. Ironveld Plc | Orchestra BioMed vs. Freedom Internet Group |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Other Complementary Tools
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |